
L-Cystine diethyl ester | CAS:583-89-1
L-Cystine diethyl ester
- 名称:L-胱氨酸二乙酯 | L-Cystine diethyl ester
- CAS号:583-89-1
- 别名:
- 分子式:C10H20N2O4S2
- 分子量:296.41
- EINESC号:
产品描述
物理化学性质
密度 | 1.252±0.06 g/cm3 (20 º |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Comparison of SSI with APCI as an interface of HPLC-mass spectrometry for analysis of a drug and its metabolites.Tetsuya Arinobu et al.Journal of the American Society for Mass Spectrometry, 13(3), 204-208 (2002-03-23)
In-vitro characterization of the cytochrome P450 isoenzymes involved in the back oxidation and N-dealkylation of reduced haloperidol.L P Pan et al.Pharmacogenetics, 8(5), 383-389 (1998-11-24)
Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.José M Entrena et al.Psychopharmacology, 205(1), 21-33 (2009-03-28)
Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage.Ilse Weuts et al.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 25(4-5), 387-393 (2005-05-17)
Determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, by gas chromatography with electron-capture detection.J Fang et al.Journal of chromatography. B, Biomedical applications, 682(2), 283-288 (1996-07-12)
[Chemical toxicological analysis of haloperidol metabolite 4-(4-chlorophenyl)-4-hydroxypipiridine in urine by high-performance liquid chromatography].A B Skorniakova et al.Sudebno-meditsinskaia ekspertiza, 52(1), 45-48 (2009-04-18)
Sensitive determination of 4-(4-chlorophenyl)-4-hydroxypiperidine, a metabolite of haloperidol, in a rat biological sample by HPLC with fluorescence detection after pre-column derivatization using 4-fluoro-7-nitro-2,1,3-benzoxadiazole.Yasuhiko Higashi et al.Biomedical chromatography : BMC, 20(9), 964-970 (2006-03-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!